Bo Wei
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- Circular RNAs in diseases 3
- Epigenetics and DNA Methylation 2
-
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Iqbal Mahmud (4 shared papers)Philip L. Lorenzi (6 shared papers)Dongbing Ding (3 shared papers)Jiannan Ren (3 shared papers)Rongpu Liang (3 shared papers)Shengxin Huang (3 shared papers)Mi Li (1 shared paper)Masha V. Poyurovsky (1 shared paper)
- Journals
- Nature Communications (2 papers)Frontiers in Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)Cell Death Discovery (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Bo Wei
16 papers receiving 260 citations
Bo Wei's Hit Papers
Peers
Comparison fields: 5 of 50
- Cancer Research 114
- Molecular Biology 158
- Pulmonary and Respiratory Medicine 71
- Immunology 29
- Oncology 32
Countries citing papers authored by Bo Wei
This map shows the geographic impact of Bo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wei more than expected).
Fields of papers citing papers by Bo Wei
This network shows the impact of papers produced by Bo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wei. The network helps show where Bo Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance Hit paper breakdown → | 2024 | 65 |
| 2 | 2023 | 42 | |
| 3 | 2023 | 36 | |
| 4 | 2022 | 27 | |
| 5 | 2022 | 26 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 10 | |
| 8 | 2022 | 7 | |
| 9 | 2023 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2024 | 5 | |
| 13 | 2025 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Bo Wei
Bo Wei is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Biochemistry, having authored 20 papers that have together received 263 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (2 papers), Nanoplatforms for cancer theranostics (2 papers), Cancer, Lipids, and Metabolism (2 papers), Epigenetics and DNA Methylation (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (114 citations), Molecular Biology (158 citations), Pulmonary and Respiratory Medicine (71 citations), Immunology (29 citations) and Oncology (32 citations). Bo Wei has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Iqbal Mahmud, Philip L. Lorenzi, Dongbing Ding, Jiannan Ren, Rongpu Liang, Shengxin Huang, Mi Li, Masha V. Poyurovsky, Li Zhuang and Khandan Keyomarsi. Their work appears in journals such as Nature Communications, Frontiers in Oncology, Molecular Cancer Therapeutics, Cell Death Discovery and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.